Sensei Biotherapeutics, Inc. Share Price & Technical Analysis
SNSE · $17.79 (+1.31%)
Healthcare / Biotechnology
$17.79
+1.31%
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune c…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-35% return in May, -16% avg return in past 3 year May month.
170% return in 2026, -9% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -9% | 224% | 6% | -16% | -35% | – | – | – | – | – | – | – | 170% |
| 25 | -4% | 2% | -14% | 9% | -24% | 43% | -17% | 12% | 15% | -3% | -8% | 27% | 39% |
| 24 | 15% | 9% | 33% | -4% | -24% | -18% | 8% | -8% | 0% | -19% | 13% | -9% | -5% |
| 23 | -3% | 10% | -4% | -2% | 1% | -22% | 7% | -21% | -20% | -11% | 4% | 0% | -62% |
| 22 | -16% | -23% | -37% | -35% | 20% | 18% | -14% | 1% | -19% | -17% | -5% | 5% | -122% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Oversold
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$28.96M
P/E ratio
—
52W high
$36.76
52W low
$5.32
Volume
21,034
Beta
-0.18
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Sensei Biotherapeutics, Inc. share price today?
- Sensei Biotherapeutics, Inc. (SNSE) last traded around $17.79 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SNSE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SNSE. Download the app for real-time alerts.
- How can I analyze Sensei Biotherapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.